Drug Makers Raise Prices in Face of Health Care Reform
Critics say the industry is trying to establish a higher price base before Congress passes legislation that tries to curb drug spending in coming years.br clear=both style=clear: both;/
br clear=both style=clear: both;/
a href=http://ads.pheedo.com/click.phdo?s=39ba7fb603d0d0e6adddf2bf646e5e65p=1img alt= style=border: 0; border=0 src=http://ads.pheedo.com/img.phdo?s=39ba7fb603d0d0e6adddf2bf646e5e65p=1//a
img alt= height=0 width=0 border=0 style=display:none src=http://a.rfihub.com/eus.gif?eui=2220/
http://feeds.nytimes.com/click.phdo?i=39ba7fb603d0d0e6adddf2bf646e5e65
